Merge closes deal, raises cash

Article

The acquisition of RIS Logic is done. Merge eFilm has closed the previously announced deal (SCAN 7/23/03) to acquire the privately held Ohio-based company, which specializes in the development of software for radiology information systems. The final

The acquisition of RIS Logic is done. Merge eFilm has closed the previously announced deal (SCAN 7/23/03) to acquire the privately held Ohio-based company, which specializes in the development of software for radiology information systems. The final price tag is $2.725 million in cash plus 772,000 shares of Merge Technologies common stock and the issuance of replacement employee stock options. RIS Logic will operate as a division of Merge eFilm and will maintain its Cleveland office location. Dan Quigg, former RIS Logic president and CEO, will serve as president of the RIS Logic division.

A private placement of 667,000 shares of common stock will more than offset the cost of the deal. The shares, sold to institutional investors at $12 apiece, have bolstered the company's coffers by slightly more than $8 million.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.